STOCK TITAN

OABI (OABI) insider files to sell common shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

OABI filed a notice that an insider plans to sell common shares under Rule 144. The filing lists planned sales of 20,483 and 30,451 common shares through Morgan Stanley Smith Barney, with aggregate market values of 34821.10 and 51766.70, respectively, on the NASDAQ on 02/17/2026 and 02/18/2026.

The shares come from restricted stock granted by the issuer as compensation, including 36,458 securities acquired on 02/16/2026 and 58,333 on 02/18/2026. The filing notes 143,955,400 common shares outstanding. It also discloses a prior sale of 13,666 common shares for gross proceeds of 26798.27 on 12/08/2025.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the OABI Form 144 filing disclose?

The Form 144 for OABI discloses an insider’s intention to sell specific amounts of common stock. It lists the planned sale dates, share counts, market values, and that the shares are restricted stock originally granted as compensation by the issuer.

How many OABI shares are planned for sale under this Form 144?

The notice lists planned sales of 20,483 and 30,451 OABI common shares. These transactions are scheduled for 02/17/2026 and 02/18/2026, respectively, with both trades routed through Morgan Stanley Smith Barney on the NASDAQ market.

What is the aggregate market value of OABI shares to be sold?

The planned OABI share sales have aggregate market values of 34821.10 and 51766.70. These values correspond to the two separate planned transactions, each involving OABI common stock to be sold on NASDAQ through Morgan Stanley Smith Barney.

How were the OABI shares in this Form 144 originally acquired?

The OABI shares were acquired as restricted stock compensation from the issuer. The filing shows 36,458 securities acquired on 02/16/2026 and 58,333 on 02/18/2026, with compensation listed as the nature of payment for both acquisition dates.

How many OABI shares are outstanding compared to those being sold?

The filing reports 143,955,400 OABI common shares outstanding. The planned Rule 144 sales cover tens of thousands of shares, which is small relative to this overall outstanding share count disclosed in the document for context.

Were there recent past sales of OABI stock by the same seller?

Yes. The document lists a prior sale of 13,666 OABI common shares on 12/08/2025. That earlier transaction generated gross proceeds of 26798.27, and is reported alongside the newly planned Rule 144 sales.
OmniAb, Inc.

NASDAQ:OABI

OABI Rankings

OABI Latest News

OABI Latest SEC Filings

OABI Stock Data

246.16M
106.07M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
EMERYVILLE